Identification Generic Name ({3-[1-(4-Hydroxy-2-oxo-2H-chromen-3-yl)-propyl]-phenylcarbamoyl}-methyl)-carbamic acid tert-butyl ester DrugBank Accession Number DB08664 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for ({3-[1-(4-Hydroxy-2-oxo-2H-chromen-3-yl)-propyl]-phenylcarbamoyl}-methyl)-carbamic acid tert-butyl ester (DB08664) ×  Close Weight Average: 452.4996  Monoisotopic: 452.194736638  Chemical Formula C 25 H 28 N 2 O 6 Synonyms tert-butyl N-[({3-[(1S)-1-(4-hydroxy-2-oxo-2H-chromen-3-yl)propyl]phenyl}carbamoyl)methyl]carbamate Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Gag-Pol polyprotein Not Available HIV-2 Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as 4-hydroxycoumarins. These are coumarins that contain one or more hydroxyl groups attached to C4-position the coumarin skeleton. Kingdom Organic compounds Super Class Phenylpropanoids and polyketides Class Coumarins and derivatives Sub Class Hydroxycoumarins Direct Parent 4-hydroxycoumarins Alternative Parents Alpha amino acid amides  /  1-benzopyrans  /  Phenylpropanes  /  Anilides  /  N-arylamides  /  Pyranones and derivatives  /  Vinylogous acids  /  Carbamate esters  /  Heteroaromatic compounds  /  Secondary carboxylic acid amides  /  Organic carbonic acids and derivatives  /  Lactones  /  Oxacyclic compounds  /  Hydrocarbon derivatives  /  Organic oxides  /  Organopnictogen compounds  /  Carbonyl compounds 
 
 
  show 7 more Substituents 1-benzopyran  /  4-hydroxycoumarin  /  Alpha-amino acid amide  /  Alpha-amino acid or derivatives  /  Anilide  /  Aromatic heteropolycyclic compound  /  Benzenoid  /  Benzopyran  /  Carbamic acid ester  /  Carbonic acid derivative  /  Carbonyl group  /  Carboxamide group  /  Carboxylic acid derivative  /  Heteroaromatic compound  /  Hydrocarbon derivative  /  Lactone  /  Monocyclic benzene moiety  /  N-arylamide  /  N-substituted-alpha-amino acid  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organoheterocyclic compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Oxacycle  /  Phenylpropane  /  Pyran  /  Pyranone  /  Secondary carboxylic acid amide  /  Vinylogous acid 
 
 
  show 22 more Molecular Framework Aromatic heteropolycyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key QUQQVMVIWCUYFV-KRWDZBQOSA-N InChI InChI=1S/C25H28N2O6/c1-5-17(21-22(29)18-11-6-7-12-19(18)32-23(21)30)15-9-8-10-16(13-15)27-20(28)14-26-24(31)33-25(2,3)4/h6-13,17,29H,5,14H2,1-4H3,(H,26,31)(H,27,28)/t17-/m0/s1 IUPAC Name tert-butyl N-[({3-[(1S)-1-(4-hydroxy-2-oxo-2H-chromen-3-yl)propyl]phenyl}carbamoyl)methyl]carbamate SMILES CC[C@@H](C1=CC(NC(=O)CNC(=O)OC(C)(C)C)=CC=C1)C1=C(O)C2=CC=CC=C2OC1=O References General References Not Available External Links PubChem Compound 54689025 PubChem Substance 99445135 ChemSpider 25058338 BindingDB 1924 ZINC ZINC000100036952 PDBe Ligand U04 PDB Entries 4upj Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.00464 mg/mL ALOGPS logP 3.59 ALOGPS logP 3.54 Chemaxon logS -5 ALOGPS pKa (Strongest Acidic) 5.49 Chemaxon pKa (Strongest Basic) -6.7 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 113.96 Å 2 Chemaxon Rotatable Bond Count 8 Chemaxon Refractivity 124.74 m 3 ·mol -1 Chemaxon Polarizability 48.45 Å 3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.7874 Blood Brain Barrier - 0.9063 Caco-2 permeable - 0.6917 P-glycoprotein substrate Substrate 0.8705 P-glycoprotein inhibitor I Non-inhibitor 0.5565 P-glycoprotein inhibitor II Non-inhibitor 0.943 Renal organic cation transporter Non-inhibitor 0.9587 CYP450 2C9 substrate Non-substrate 0.7532 CYP450 2D6 substrate Non-substrate 0.8156 CYP450 3A4 substrate Substrate 0.6262 CYP450 1A2 substrate Non-inhibitor 0.6562 CYP450 2C9 inhibitor Non-inhibitor 0.7535 CYP450 2D6 inhibitor Non-inhibitor 0.8532 CYP450 2C19 inhibitor Non-inhibitor 0.5952 CYP450 3A4 inhibitor Non-inhibitor 0.8965 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.6574 Ames test Non AMES toxic 0.6968 Carcinogenicity Non-carcinogens 0.7943 Biodegradation Not ready biodegradable 1.0 Rat acute toxicity 2.7411 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.975 hERG inhibition (predictor II) Non-inhibitor 0.8691    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Gag-Pol polyprotein Kind Protein Organism HIV-2 Pharmacological action Unknown General Function Zinc ion binding Specific Function Gag-Pol polyprotein: Mediates, with Gag polyrotein, the essential events in virion assembly, including binding the plasma membrane, making the protein-protein interactions necessary to create spher... Gene Name gag-pol Uniprot ID P04584 Uniprot Name Gag-Pol polyprotein Molecular Weight 164644.035 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:33 / Updated at June 12, 2020 16:52 